Edesa Biotech, Inc. - FORM 10-K - EX-23.1 - CONSENTS OF EXPERTS AND COUNSEL - December 7, 2020

Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Edesa Biotech, Inc.edsa_ex312.htm
10-K - ANNUAL REPORT - Edesa Biotech, Inc.edsa_10k.htm
EX-32.2 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - Edesa Biotech, Inc.edsa_ex322.htm
EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - Edesa Biotech, Inc.edsa_ex321.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Edesa Biotech, Inc.edsa_ex311.htm
EX-21 - SUBSIDIARIES OF THE REGISTRANT - Edesa Biotech, Inc.edsa_ex21.htm
EX-10.21 - EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND KATHI NIFFENEGGER - Edesa Biotech, Inc.edsa_ex1021.htm
  Exhibit 23.1

Consent of Independent Registered Public Accounting Firm
 
 
We hereby consent to the incorporation by reference in Registration Statement Nos. 333-217480 and 333-236121 on Form S-8, Registration Statement No. 333-233567 on Form S-3 and Registration Statement No. 333-236608 on Form S-1 of Edesa Biotech, Inc. of our report dated December 7, 2020, relating to the consolidated financial statements of Edesa Biotech, Inc. for the year ended September 30, 2020 and the nine-month period ended September 30, 2019, which report appears in this Annual Report on Form 10-K for the year ended September 30, 2020.
 
 
/s/ MNP LLP
Chartered Professional Accountants
Licensed Public Accountants
 
Toronto, Canada
December 7, 2020
 
 

Edesa Biotech, Inc. Reports